Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease. (22nd July 2014)
- Record Type:
- Journal Article
- Title:
- Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease. (22nd July 2014)
- Main Title:
- Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
- Authors:
- Pereira, Isabela Resende
Vilar-Pereira, Glaucia
Silva, Andrea Alice
Moreira, Otacilio Cruz
Britto, Constança
Sarmento, Ellen Diana Marinho
Lannes-Vieira, Joseli - Other Names:
- Chevillard Christophe Academic Editor.
- Abstract:
- Abstract : Background . Chagas disease (CD) is characterized by parasite persistence and immunological unbalance favoring systemic inflammatory profile. Chronic chagasic cardiomyopathy, the main manifestation of CD, occurs in a TNF-enriched milieu and frequently progresses to heart failure. Aim of the Study . To challenge the hypothesis that TNF plays a key role in Trypanosoma cruzi -induced immune deregulation and cardiac abnormalities, we tested the effect of the anti-TNF antibody Infliximab in chronically T. cruzi -infected C57BL/6 mice, a model with immunological, electrical, and histopathological abnormalities resembling Chagas' heart disease. Results . Infliximab therapy did not reactivate parasite but reshaped the immune response as reduced TNF mRNA expression in the cardiac tissue and plasma TNF and IFN γ levels; diminished the frequency of IL-17A + but increased IL-10 + CD4 + T-cells; reduced TNF + but augmented IL-10 + Ly6C + and F4/80 + cells. Further, anti-TNF therapy decreased cytotoxic activity but preserved IFN γ -producing VNHRFTLV-specific CD8 + T-cells in spleen and reduced the number of perforin + cells infiltrating the myocardium. Importantly, Infliximab reduced the frequency of mice afflicted by arrhythmias and second degree atrioventricular blocks and decreased fibronectin deposition in the cardiac tissue. Conclusions . Our data support that TNF is a crucial player in the pathogenesis of Chagas' heart disease fueling immunological unbalance whichAbstract : Background . Chagas disease (CD) is characterized by parasite persistence and immunological unbalance favoring systemic inflammatory profile. Chronic chagasic cardiomyopathy, the main manifestation of CD, occurs in a TNF-enriched milieu and frequently progresses to heart failure. Aim of the Study . To challenge the hypothesis that TNF plays a key role in Trypanosoma cruzi -induced immune deregulation and cardiac abnormalities, we tested the effect of the anti-TNF antibody Infliximab in chronically T. cruzi -infected C57BL/6 mice, a model with immunological, electrical, and histopathological abnormalities resembling Chagas' heart disease. Results . Infliximab therapy did not reactivate parasite but reshaped the immune response as reduced TNF mRNA expression in the cardiac tissue and plasma TNF and IFN γ levels; diminished the frequency of IL-17A + but increased IL-10 + CD4 + T-cells; reduced TNF + but augmented IL-10 + Ly6C + and F4/80 + cells. Further, anti-TNF therapy decreased cytotoxic activity but preserved IFN γ -producing VNHRFTLV-specific CD8 + T-cells in spleen and reduced the number of perforin + cells infiltrating the myocardium. Importantly, Infliximab reduced the frequency of mice afflicted by arrhythmias and second degree atrioventricular blocks and decreased fibronectin deposition in the cardiac tissue. Conclusions . Our data support that TNF is a crucial player in the pathogenesis of Chagas' heart disease fueling immunological unbalance which contributes to cardiac abnormalities. … (more)
- Is Part Of:
- Mediators of inflammation. Volume 2014(2014)
- Journal:
- Mediators of inflammation
- Issue:
- Volume 2014(2014)
- Issue Display:
- Volume 2014, Issue 2014 (2014)
- Year:
- 2014
- Volume:
- 2014
- Issue:
- 2014
- Issue Sort Value:
- 2014-2014-2014-0000
- Page Start:
- Page End:
- Publication Date:
- 2014-07-22
- Subjects:
- Inflammation -- Mediators -- Periodicals
Biological response modifiers -- Periodicals
Inflammation (Pathologie) -- Médiateurs
Immunomodulateurs
Biological response modifiers
Inflammation -- Mediators
Immunology
Autacoids
Immunologic Factors
Cell Adhesion Molecules
Cell Communication
Cytokines
Inflammation
Periodicals
Electronic journals
616.0473 - Journal URLs:
- https://www.hindawi.com/journals/mi/ ↗
- DOI:
- 10.1155/2014/798078 ↗
- Languages:
- English
- ISSNs:
- 0962-9351
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 23451.xml